Full Speed Ahead: For Joyful Movement and Health (fullspeed)

January 25, 2026 updated by: Ann-Christin Eliasson, Karolinska Institutet

The aim of this project is to implement and evaluate the effects of a mobility-focused training program, including the use of running frames, on gross motor function and physical activity levels in children aged 2-5 years with cerebral palsy. The hypothesis is that these children can improve their mobility with or without assistive devices, that the training program will influence their overall activity level, and that it will provide cardiovascular exercise leading to improved fitness and muscle development.

In previous studies, the investigators have observed positive health-related outcomes in older children. Recently, three-wheeled Frame Running bikes designed for very young children have become available; however, no research has been conducted on these devices or their potential effects in toddlers.

In this project, group training sessions will be offered to children aged 2-5 years. Participants will receive mobility and gait training with or without assistive devices, depending on individual needs. The three-wheeled Frame Running bike will be included as one training component, although participants may use other assistive aids as needed. Training is planned as play-based activities together with peers, for one hour per week over a 12-week period, complemented by home-based exercises.

Study Overview

Status

Enrolling by invitation

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Stockholm, Sweden
        • Department of Woman's and Children's health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

GMFCS II-V

Exclusion Criteria:

severe intelectual disability

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: intervention
Frame running and gross motor training
12 weeks of daily training at home and 1 group training session /week including both Frame running and grossmotor training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gross Motor Function MEasure (GMFM)
Time Frame: From enrollment to the end of treatment at 3 month
Measure gross motor function in children with CP from 6 month to 18 years, the scale ranging from 0-100 units, higher is better
From enrollment to the end of treatment at 3 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sens motion, Accelerometry
Time Frame: From enrollment to the end of intervention at 3 months
Measure physical activity in daily life
From enrollment to the end of intervention at 3 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional mobility scale (FMS)
Time Frame: From enrollment to the end of treatment at 3 months
Measure childrens ability to walk on a 5 graded scale
From enrollment to the end of treatment at 3 months
Pediatric Evaluation of the Disability Inventory (PEDI- CAT)
Time Frame: From enrollment to the end of treatment at 3 month
Mobility module measure childrens ability to move in the environment on a 0-100 scale
From enrollment to the end of treatment at 3 month
Time up and Go (TUG)
Time Frame: From enrollment to the end of treatment at 3 months
Measure balans in standing and motion, mesaure in seconds
From enrollment to the end of treatment at 3 months
Goal Attainment scale (GAS)
Time Frame: From enrollment to the end of treatment at 3 month
Measure individualized goals, based a a 5-graded scale
From enrollment to the end of treatment at 3 month
Ultra sound
Time Frame: From enrollment to the end of treatment at 3 months
Measure the muscles thickness and form
From enrollment to the end of treatment at 3 months
Pediatrice Rehabilitation Intervention Measure of Engagement for Parents (Prime P)
Time Frame: From enrollment to the end of treatment at 3 month
Descrieb the parents engagement in treatment
From enrollment to the end of treatment at 3 month
Service Provider-Rated Measure of Client Engagement (Prime SP)
Time Frame: From enrollment to the end of treatment at 3 month
Describe the therapist's assessment of the child's engagement
From enrollment to the end of treatment at 3 month
Wrist-worn heart rate monitor
Time Frame: From enrollment to the end of treatment at 3 weeks
Measure the pulse continously during certain period
From enrollment to the end of treatment at 3 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 7, 2024

Primary Completion (Estimated)

December 30, 2026

Study Completion (Estimated)

December 30, 2026

Study Registration Dates

First Submitted

November 18, 2025

First Submitted That Met QC Criteria

January 25, 2026

First Posted (Actual)

January 28, 2026

Study Record Updates

Last Update Posted (Actual)

January 28, 2026

Last Update Submitted That Met QC Criteria

January 25, 2026

Last Verified

September 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • Dnr 2024-05809-01
  • Privat donations 3 500 000 SEK (Other Identifier: Karolinska Institutet)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Patient data and we need to know more about the result

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebral Palsy

Clinical Trials on Full speed ahead

Subscribe